Next Article in Journal
An Fc-Optimized CD133 Antibody for Induction of Natural Killer Cell Reactivity Against Colorectal Cancer
Previous Article in Journal
Ramucirumab and GSK1838705A Enhance the Inhibitory Effects of Low Concentration Sorafenib and Regorafenib Combination on HCC Cell Growth and Motility
 
 
Article

Article Versions Notes

Cancers 2019, 11(6), 788; https://doi.org/10.3390/cancers11060788
Action Date Notes Link
article xml file uploaded 7 June 2019 11:52 CEST Original file -
article xml uploaded. 7 June 2019 11:52 CEST Update https://www.mdpi.com/2072-6694/11/6/788/xml
article pdf uploaded. 7 June 2019 11:52 CEST Version of Record https://www.mdpi.com/2072-6694/11/6/788/pdf
article supplementary file uploaded. 7 June 2019 11:52 CEST - https://www.mdpi.com/2072-6694/11/6/788#supplementary
article html file updated 7 June 2019 11:53 CEST Original file -
article html file updated 10 June 2019 05:05 CEST Update -
article html file updated 5 July 2019 19:04 CEST Update -
article html file updated 5 July 2019 19:05 CEST Update -
article html file updated 21 October 2019 12:53 CEST Update -
article html file updated 12 February 2020 18:19 CET Update -
article html file updated 20 July 2022 15:55 CEST Update https://www.mdpi.com/2072-6694/11/6/788/html
Back to TopTop